Find a Drug
Advanced Search

Professional

Ertaczo

Clinical Pharmacology
font size

CLINICAL PHARMACOLOGY

Pharmacokinetics: In a multiple dose pharmacokinetic study that included 5 male patients with interdigital tinea pedis (range of diseased area, 42 140 cm2; mean, 93 cm2), ERTACZO™ Cream, 2%, was topically applied every 12 hours for a total of 13 doses to the diseased skin (0.5 grams sertaconazole nitrate per 100 cm2). Sertaconazole concentrations in plasma measured by serial blood sampling for 72 hours after the thirteenth dose were below the limit of quantitation (2.5 ng/mL) of the analytical method used.

Microbiology: Sertaconazole is an antifungal that belongs to the imidazole class of antifungals. While the exact mechanism of action of this class of antifungals is not known, it is believed that they act primarily by inhibiting the cytochrome P450-dependent synthesis of ergosterol. Ergosterol is a key component of the cell membrane of fungi, and lack of this component leads to fungal cell injury primarily by leakage of key constituents in the cytoplasm from the cell.

Activity In Vivo: Sertaconazole nitrate has been shown to be active against isolates of the following microorganisms in clinical infections as described in the INDICATIONS AND USAGE section:

Trichophyton rubrum

Trichophyton mentagrophytes

Epidermophyton floccosum

CLINICAL STUDIES

In two randomized, double-blind, clinical trials, patients 12 years and older with interdigital tinea pedis applied either ERTACZO™ Cream, 2%, or vehicle, twice daily for four weeks. Patients with moccasin-type (plantar) tinea pedis and/or onychomycosis were excluded from the study. Two weeks after completion of therapy (six weeks after beginning therapy), patients were evaluated for signs and symptoms related to interdigital tinea pedis.

Treatment outcomes are summarized in the table below.

Treatment Outcomes as Percent (%) of Total Subjects
 
Study 1
Study 2
 
Sertaconazole
Vehicle
Sertaconazole
Vehicle
Complete Cure*
(Primary Efficacy Variable)
13/99 (13.1%)
3/92 (3.3%)
28/103 (27.2%)
5/103 (4.9%)
Effective Treatment**
32/99 (32.3%)
11/92 (12.0%)
52/103 (50.5%)
16/103 (15.5%)
Mycological Cure***
49/99 (49.5%)
18/92 (19.6%)
71/103 (68.9%)
20/103 (19.4%)

* Complete Cure - Patients who had complete clearing of signs and symptoms and Mycological Cure
** Effective Treatment - Patients who had minimal residual signs and symptoms of interdigitial tinea pedis and Mycological Cure
*** Mycological Cure - Patients who had both negative microscopic KOH preparation and a negative fungal culture.

Brand Name: Ertaczo
Generic Name: Sertaconazole Nitrate

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

Skin & Beauty

Get beauty tips and body treatments.

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

Cellulite Treatment with HeatCellulite Treatment with Heat
Most women over 20 have it and hate it, but the bumpy look of cellulite under the skin isn't easy to erase. But a hot technology may change that. See more WebMD Videos »